125.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$124.88
Aprire:
$125.6
Volume 24 ore:
1.53M
Relative Volume:
0.76
Capitalizzazione di mercato:
$35.58B
Reddito:
$6.95B
Utile/perdita netta:
$1.30B
Rapporto P/E:
27.53
EPS:
4.5696
Flusso di cassa netto:
$1.15B
1 W Prestazione:
-2.91%
1M Prestazione:
-14.02%
6M Prestazione:
+4.59%
1 anno Prestazione:
-7.80%
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Technologies (NYSE:A) Boosts The S&P 500 Fund With Scientific Excellence - Kalkine Media
Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent (A) Secures FDA Approval for Key Cancer Diagnostic Tool - GuruFocus
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Yahoo Finance
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award - marketscreener.com
Is Agilent Technologies Inc. showing insider buyingRate Cut & Low Risk High Reward Trade Ideas - mfd.ru
Agilent Slumps After Awarding Boehringer - Baystreet.ca
Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance - marketscreener.com
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Bluefield Daily Telegraph
Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat
Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence - Quantisnow
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
Candriam S.C.A. Increases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Federated Hermes Inc. Has $273,000 Stock Position in Agilent Technologies, Inc. $A - MarketBeat
AGILENT TECHNOLOGIES, INC. ($A) CEO 2025 Pay Revealed - Quiver Quantitative
AAgilent Technologies Inc Stock Price and Quote - Finviz
What's Driving the Market Sentiment Around Agilent Technologies Inc? - Benzinga
Form DEFA14A AGILENT TECHNOLOGIES, - StreetInsider
Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase - Sahm
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet? - Yahoo Finance
Agilent Ekes up Ahead of Next Week’s Boston Fair - Baystreet.ca
Agilent Technologies Inc. Showcases Next-Generation Automated Solutions at SLAS2026 - marketscreener.com
Allianz Asset Management GmbH Has $96.71 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - BioSpace
Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com
Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews
Agilent Technologies price tries to recoup some lossesForecast today02-02-2026 - Economies.com
National Pension Service Acquires 11,841 Shares of Agilent Technologies, Inc. $A - MarketBeat
AE Wealth Management LLC Has $9.54 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Chromatograph (Labor): Why Agilent’s Lab Chromatography Systems Are Quietly Powering the Most Impo - AD HOC NEWS
Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Mutual of America Capital Management LLC Sells 12,121 Shares of Agilent Technologies, Inc. $A - MarketBeat
Chromatography Research Report 2026 - GlobeNewswire Inc.
Automated Sample Preparation Research Report 2026 - GlobeNewswire Inc.
Bank of New York Mellon Corp Trims Stake in Agilent Technologies, Inc. $A - MarketBeat
Published on: 2026-01-30 09:44:59 - baoquankhu1.vn
EPS Watch: Whats the beta of Agilent Technologies Inc stock2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):